跳至主要内容
临床试验/NCT03422042
NCT03422042已完成不适用

An Open-labeled, Randomized Controlled Trial Comparing Between Short Duration And Standard Fourteen Days Antibiotic Treatments In Patients With Acute Common Bile Duct Stone Cholangitis After Successful Endoscopic Biliary Drainage

Prince of Songkla University2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2017年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
The recurrence rate of cholangitis

研究概览

简要总结

Common bile duct stone cholangitis is a potentially fatal condition, characterized by an obstruction and bacterial infection of biliary system. The principles of management are appropriate biliary drainage and systemic antibiotics. There has been limited data about appropriate time of antibiotics in patient with successful endoscopic drainage.

详细描述

The aim is comparing the efficacy and safety between short duration and standard fourteen days antibiotic treatment in patients with acute common bile duct stone (CBDS) cholangitis after successful endoscopic biliary drainage as regards recurrence rate of acute cholangitis, complete stone clearance rate, morbidity and mortality associated acute cholangitis, and complications related ERCP procedure.

The study will be divided patients with acute CBDS cholangitis with complete stone clearance into 2 groups, group (A) will be received intravenous antibiotic until the temperature is less than 37.8 c for 72 hours and group (B) will be received intravenous antibiotic for 7 days, followed by oral antibiotic for 7 days, regardless of the body temperature.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years old
  • diagnosis of acute mild to moderate severity of ascending common bile duct stone cholangitis
  • endoscopic retrograde cholangiopancreatography (ERCP) with biliary drainage within 72 hours after admission

排除标准

  • pregnant woman
  • the cause of obstruction other than common bile duct stone
  • severe co-morbid diseases such as cardiovascular/pulmonary/kidney disease
  • active concomitant infections of other organs
  • history of allergy to cephalosporin group

结局指标

主要结局

The recurrence rate of cholangitis

时间窗: 8 weeks

The number of patients who has recurrence of fever after complete treatment without other sources identified

次要结局

  • Mortality rate(4 weeks)
  • The rate of adequacy of drainage(24 hours)
  • Complication rate(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nisa Netinatsunton

Principal Investigator

Prince of Songkla University

研究点 (2)

Loading locations...

相似试验